Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Champions Oncology Q4 Adj. EPS $(0.07) Beats $(0.20) Estimate, Sales $12.355M Beat $12.013M Estimate

Author: Benzinga Newsdesk | July 23, 2025 04:01pm
Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.20) by 65 percent. This is a 800 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $12.355 million which beat the analyst consensus estimate of $12.013 million by 2.85 percent. This is a 11.76 percent decrease over sales of $14.001 million the same period last year.

Posted In: CSBR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist